Genetic Deficiencies of Monoamine Oxidase Enzymes: A Key to Understanding the Function of the Enzymes in Humans

Advances in Pharmacology

Volumn 42, Issue C, 1997, Pages 297-301

  Lenders, Jacques W M ^a   Brunner, Han G ^a   Murphy, Dennis L ^b   Eisenhofer, Graeme ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956849890     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60748-6     Document Type: Article

References (12)

1. Weyler W., Hsu Y.-P.P., and Breakefield X.O. Biochemistry and genetics of monoamine-oxidase. Pharmacol. Ther. 47 (1990) 391-417
2. Berry M.D., Juorio A.V., and Paterson I.A. The functional role of monoamine oxidases A and B in the mammalian central nervous system. Prog. Neurobiol. 42 (1994) 375-391
3. Brunner H.G., Nelen M., Breakefield X.O., Ropers H.H., and van Oost B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262 (1993) 578-580
4. Brunner H.G., Nelen M.R., van Zandvoort P., Abeling N.G.G.M., van Gennip A.H., Wolters E.C., Kuiper M.A., Ropers H.H., and van Oost B.A. X-linked borderline mental retardation with prominent behavioral disturbance: Phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am. J. Hum. Genet. 52 (1993) 1032-1039
5. Murphy D.L., Sims K.B., Karoum F., de la Chapelle A., Norio R., Sankila E.M., and Breakefield X.O. Marked amine and amine metabolite changes in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase. J. Neurochem. 54 (1990) 242-247
6. Lenders J.W.M., Eisenhofer G., Abeling N.G.G.M., Berger W., Murphy D.L., Konings C.H., Bleeker Wagemakers L.M., Kopin I.J., Karoum F., Gennip A.H., and Brunner H.G. Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. J. Clin. Invest. 97 (1996) 1-10
7. Eisenhofer G., and Finberg J.P.M. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats. J. Pharmacol. Exp. Ther. 268 (1994) 1242-1251
8. Eisenhofer G., Friberg P., Pacak K., Goldstein D.S., Murphy D.L., Tsigos C., Quyyumi A.A., Brunner H.G., and Lenders J.W.M. Plasma metadrenalines: Do they provide useful information about sympatho-adrenal function and catecholamine metabolism. Clin. Sci. 88 (1995) 442-533
9. von Knorring L., Oreland L., and Winhlad B. Personality traits related to monoamine oxidase activity in platelets. Psychiatr. Res. 12 (1984) 11-26
10. Devor E.J., Cloninger C.R., Hoffman P.L., and Tabakoff B. Association of monoamine oxidase (MAO) activity with alcoholism and alcoholic subtypes. Am. J. Med. Genet. 48 (1993) 209-213
11. Cases O., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S., Müller U., Aguet M., Babinet C., Shih J.C., and De Maeyer E. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAO-A. Science 268 (1995) 1763-1766
12. Whitaker-Azmitia P.M., Zhang X., and Clarke C. Effects of gestational exposure to monoamine oxidase inhibitors in rats: Preliminary behavioral and neurochemical studies. Neuropsychopharmacology 11 (1994) 125-132